Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 445
Gene Symbol: ASS1
ASS1
0.010 AlteredExpression disease BEFREE In this study, comprehensive analysis of the expression profiles of the genes associated with the polarization of M0-type PAMs (resting) toward M1 phenotypes (activated by IFN-γ and LPS) led to the following main results: 1) 1551 and 1823 genes were upregulated or downregulated in M1-type PAMs, respectively, compared with M0-type PAMs; 2) Among these, genes encoding ASS1 and CRTAM were the most upregulated and downregulated, respectively; 3) Genes involved in cytokine-cytokine receptor interaction and the JAK/STAT signaling pathway were significantly upregulated, suggesting their critical role in cellular activation; and 4) Genes involved in antigen proteolysis and presentation (immunoproteasome subunits), and inhibition of virus replication (host restriction factors) were significantly upregulated, emphasizing the critical role of these cytokines in immunity. 30086883 2018
Entrez Id: 54897
Gene Symbol: CASZ1
CASZ1
0.010 Biomarker disease BEFREE An optimal nanoprecipitation yield of 76% was obtained allowing encapsulation of solid CST within FN-PAM-CST, which released CST in a prolonged manner. 27887883 2017
Entrez Id: 2826
Gene Symbol: CCR10
CCR10
0.010 GeneticVariation disease BEFREE There was a statistically significant difference between the IRS in nevi and PAM with atypia for nuclear IRS in CCR10 (P = 0.03) and both nuclear and cytoplasmic IRS in CXCR4 (P < 0.01 and P = 0.03, respectively); this was also true evaluating the groups PAM with atypia and melanoma all together (P < 0.01). 31305861 2019
Entrez Id: 1180
Gene Symbol: CLCN1
CLCN1
0.020 GeneticVariation disease BEFREE SCN4A exons with known SCM mutations were subsequently sequenced in families where no CLCN1 mutations were found. 17998485 2007
Entrez Id: 1180
Gene Symbol: CLCN1
CLCN1
0.020 GeneticVariation disease BEFREE Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia. 25088311 2014
Entrez Id: 56253
Gene Symbol: CRTAM
CRTAM
0.010 AlteredExpression disease BEFREE In this study, comprehensive analysis of the expression profiles of the genes associated with the polarization of M0-type PAMs (resting) toward M1 phenotypes (activated by IFN-γ and LPS) led to the following main results: 1) 1551 and 1823 genes were upregulated or downregulated in M1-type PAMs, respectively, compared with M0-type PAMs; 2) Among these, genes encoding ASS1 and CRTAM were the most upregulated and downregulated, respectively; 3) Genes involved in cytokine-cytokine receptor interaction and the JAK/STAT signaling pathway were significantly upregulated, suggesting their critical role in cellular activation; and 4) Genes involved in antigen proteolysis and presentation (immunoproteasome subunits), and inhibition of virus replication (host restriction factors) were significantly upregulated, emphasizing the critical role of these cytokines in immunity. 30086883 2018
Entrez Id: 106478911
Gene Symbol: CST12P
CST12P
0.010 Biomarker disease BEFREE An optimal nanoprecipitation yield of 76% was obtained allowing encapsulation of solid CST within FN-PAM-CST, which released CST in a prolonged manner. 27887883 2017
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.010 AlteredExpression disease BEFREE Beta-catenin was more strongly expressed in melanomas and nevi than in PAM (P<0.001). 28161440 2017
Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
0.010 Biomarker disease BEFREE There was a statistically significant difference between the IRS in nevi and PAM with atypia for nuclear IRS in CCR10 (P = 0.03) and both nuclear and cytoplasmic IRS in CXCR4 (P < 0.01 and P = 0.03, respectively); this was also true evaluating the groups PAM with atypia and melanoma all together (P < 0.01). 31305861 2019
Entrez Id: 1595
Gene Symbol: CYP51A1
CYP51A1
0.010 Biomarker disease BEFREE Collectively, the target-based and parasite-based data obtained in these studies validated CYP51 as a potentially 'druggable' target in N. fowleri, and conazole drugs as the candidates for assessment in the animal model of PAM. 29284029 2017
Entrez Id: 10148
Gene Symbol: EBI3
EBI3
0.010 GeneticVariation disease BEFREE In this study, comprehensive analysis of the expression profiles of the genes associated with the polarization of M0-type PAMs (resting) toward M1 phenotypes (activated by IFN-γ and LPS) led to the following main results: 1) 1551 and 1823 genes were upregulated or downregulated in M1-type PAMs, respectively, compared with M0-type PAMs; 2) Among these, genes encoding ASS1 and CRTAM were the most upregulated and downregulated, respectively; 3) Genes involved in cytokine-cytokine receptor interaction and the JAK/STAT signaling pathway were significantly upregulated, suggesting their critical role in cellular activation; and 4) Genes involved in antigen proteolysis and presentation (immunoproteasome subunits), and inhibition of virus replication (host restriction factors) were significantly upregulated, emphasizing the critical role of these cytokines in immunity. 30086883 2018
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.010 AlteredExpression disease BEFREE Our objectives were to investigate the genetic etiology and circulating level of FGF23 in a 50-year-old male with clinical characteristics of PAM and extra-pulmonary calcifications. 20960258 2010
Entrez Id: 9514
Gene Symbol: GAL3ST1
GAL3ST1
0.010 Biomarker disease BEFREE An optimal nanoprecipitation yield of 76% was obtained allowing encapsulation of solid CST within FN-PAM-CST, which released CST in a prolonged manner. 27887883 2017
Entrez Id: 2915
Gene Symbol: GRM5
GRM5
0.010 GeneticVariation disease BEFREE In hippocampal slices subjected to 30 min oxygen-glucose deprivation (OGD), DHPG (1 μM) and the mGluR5 PAM (VU0092273) significantly reduced OGD-induced CA1 injury monitored by propidium iodide staining of the slices and quantitative analysis of CA1 neurons. 31600563 2020
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.010 AlteredExpression disease BEFREE In this study, comprehensive analysis of the expression profiles of the genes associated with the polarization of M0-type PAMs (resting) toward M1 phenotypes (activated by IFN-γ and LPS) led to the following main results: 1) 1551 and 1823 genes were upregulated or downregulated in M1-type PAMs, respectively, compared with M0-type PAMs; 2) Among these, genes encoding ASS1 and CRTAM were the most upregulated and downregulated, respectively; 3) Genes involved in cytokine-cytokine receptor interaction and the JAK/STAT signaling pathway were significantly upregulated, suggesting their critical role in cellular activation; and 4) Genes involved in antigen proteolysis and presentation (immunoproteasome subunits), and inhibition of virus replication (host restriction factors) were significantly upregulated, emphasizing the critical role of these cytokines in immunity. 30086883 2018
Entrez Id: 8809
Gene Symbol: IL18R1
IL18R1
0.010 GeneticVariation disease BEFREE In this study, comprehensive analysis of the expression profiles of the genes associated with the polarization of M0-type PAMs (resting) toward M1 phenotypes (activated by IFN-γ and LPS) led to the following main results: 1) 1551 and 1823 genes were upregulated or downregulated in M1-type PAMs, respectively, compared with M0-type PAMs; 2) Among these, genes encoding ASS1 and CRTAM were the most upregulated and downregulated, respectively; 3) Genes involved in cytokine-cytokine receptor interaction and the JAK/STAT signaling pathway were significantly upregulated, suggesting their critical role in cellular activation; and 4) Genes involved in antigen proteolysis and presentation (immunoproteasome subunits), and inhibition of virus replication (host restriction factors) were significantly upregulated, emphasizing the critical role of these cytokines in immunity. 30086883 2018
Entrez Id: 3659
Gene Symbol: IRF1
IRF1
0.010 GeneticVariation disease BEFREE Dynamic bone labeling showed reduced calcein signal in the PAM-treated calluses (38-63%, p < 0.01) and reduced MAR (32-49%, p < 0.01), suggesting a compensatory reduction in bone anabolism. 31578632 2020
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.010 Biomarker disease BEFREE The mean score of KIT staining in the melanomas/PAMs group was significantly different from nevi (p = 0.0076). 23742652 2013
Entrez Id: 110806263
Gene Symbol: LOC110806263
LOC110806263
0.010 GeneticVariation disease BEFREE TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. 25159205 2014
Entrez Id: 5066
Gene Symbol: PAM
PAM
0.010 Biomarker disease BEFREE Since the development in the 1950's of 2-PAM (Pralidoxime), an antidote that reactivates organophosphate conjugated acetylcholinesterase in target tissues upon pesticide or nerve agent exposure, improvements in antidotal therapy have largely involved congeneric pyridinium aldoximes. 31100277 2019
Entrez Id: 54704
Gene Symbol: PDP1
PDP1
0.010 Biomarker disease BEFREE Compared with M<sub>E-D-A</sub> and M<sub>E-(A/D)</sub>, M<sub>E-A-D</sub> showed the best siRNA binding capacity to form stable M<sub>E-A-D</sub>/siRNA CMs less than 100 nm, mediated the best gene-silencing efficiency and inhibition effect of tumor cell growth in vitro, and showed better liver gene-silencing effect in vivo. 28862422 2017
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.020 Biomarker disease BEFREE The PI3K/AKT/mTOR (PAM) signaling pathway controls key cellular responses, such as cell growth and proliferation, survival, migration and metabolism. 25601471 2015
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.020 Biomarker disease BEFREE Using Real-time PCR, western blot, and immunofluorescence studies, we observed that (i) Lanatoside C inhibited cell proliferation and induced apoptosis in cell-specific and dose-dependent manner only in cancer cell lines; (ii) Lanatoside C exerts its anti-cancer activity by arresting the G2/M phase of cell cycle by blocking MAPK/Wnt/PAM signaling pathways; (iii) it induces apoptosis by inducing DNA damage and inhibiting PI3K/AKT/mTOR signaling pathways; and finally, (iv) molecular docking analysis shows significant evidence on the binding sites of Lanatoside C with various key signaling proteins ranging from cell survival to cell death. 31783627 2019
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.020 Biomarker disease BEFREE The PI3K/AKT/mTOR (PAM) signaling pathway controls key cellular responses, such as cell growth and proliferation, survival, migration and metabolism. 25601471 2015
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.020 Biomarker disease BEFREE Using Real-time PCR, western blot, and immunofluorescence studies, we observed that (i) Lanatoside C inhibited cell proliferation and induced apoptosis in cell-specific and dose-dependent manner only in cancer cell lines; (ii) Lanatoside C exerts its anti-cancer activity by arresting the G2/M phase of cell cycle by blocking MAPK/Wnt/PAM signaling pathways; (iii) it induces apoptosis by inducing DNA damage and inhibiting PI3K/AKT/mTOR signaling pathways; and finally, (iv) molecular docking analysis shows significant evidence on the binding sites of Lanatoside C with various key signaling proteins ranging from cell survival to cell death. 31783627 2019